Cargando…

Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery

INTRODUCTION: Uncertain nutritional outcomes following common metabolic surgical techniques are concerning given the long-term potential for postoperative metabolic bone disease. This study aims to investigate the variations in serum calcium, vitamin D, and parathyroid hormone (PTH) levels following...

Descripción completa

Detalles Bibliográficos
Autores principales: Suthakaran, Reshi, Indigahawela, Imeshi, Mori, Krinal, Lim, Kiat, Aly, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464128/
https://www.ncbi.nlm.nih.gov/pubmed/34563195
http://dx.doi.org/10.1186/s12893-021-01348-3
_version_ 1784572556268797952
author Suthakaran, Reshi
Indigahawela, Imeshi
Mori, Krinal
Lim, Kiat
Aly, Ahmad
author_facet Suthakaran, Reshi
Indigahawela, Imeshi
Mori, Krinal
Lim, Kiat
Aly, Ahmad
author_sort Suthakaran, Reshi
collection PubMed
description INTRODUCTION: Uncertain nutritional outcomes following common metabolic surgical techniques are concerning given the long-term potential for postoperative metabolic bone disease. This study aims to investigate the variations in serum calcium, vitamin D, and parathyroid hormone (PTH) levels following Roux-en-Y Gastric bypass (RYBP) and Sleeve Gastrectomy (SG). METHODS: A retrospective analysis of 370 patients who underwent metabolic surgery at a single-centre group practice in Melbourne, Australia, over 2 years. RESULTS: Patients underwent SG (n = 281) or RYGP (n = 89), with 75% and 87% of the cohort being female, respectively. Postoperative mean serum calcium levels and median serum vitamin D levels improved significantly by 24 months within both cohorts. Serum PTH levels within the RYBP group were significantly higher than the SG group across all time points. PTH levels significantly fell from 5.7 (IQR 4.2–7.4) to 5.00 (4.1–6.5) pmol/L by 24 months following SG. However, PTH levels following RYBP remained stable at 24 months, from 6.1 (IQR 4.7–8.7) to 6.4 (4.9–8.1) pmol/L. Furthermore, we failed to notice a significant improvement in PTH levels following RYBP among those with higher PTH levels preoperatively. CONCLUSION: Higher PTH levels following RYBP, compared to SG, may imply we are undertreating patients who are inherently subjected to a greater degree of malabsorption and underlying nutritional deficiencies. This finding calls for a tailored supplementation protocol, particularly for those with high preoperative PTH levels undergoing RYBP, to prevent deficiencies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-021-01348-3.
format Online
Article
Text
id pubmed-8464128
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84641282021-09-27 Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery Suthakaran, Reshi Indigahawela, Imeshi Mori, Krinal Lim, Kiat Aly, Ahmad BMC Surg Research INTRODUCTION: Uncertain nutritional outcomes following common metabolic surgical techniques are concerning given the long-term potential for postoperative metabolic bone disease. This study aims to investigate the variations in serum calcium, vitamin D, and parathyroid hormone (PTH) levels following Roux-en-Y Gastric bypass (RYBP) and Sleeve Gastrectomy (SG). METHODS: A retrospective analysis of 370 patients who underwent metabolic surgery at a single-centre group practice in Melbourne, Australia, over 2 years. RESULTS: Patients underwent SG (n = 281) or RYGP (n = 89), with 75% and 87% of the cohort being female, respectively. Postoperative mean serum calcium levels and median serum vitamin D levels improved significantly by 24 months within both cohorts. Serum PTH levels within the RYBP group were significantly higher than the SG group across all time points. PTH levels significantly fell from 5.7 (IQR 4.2–7.4) to 5.00 (4.1–6.5) pmol/L by 24 months following SG. However, PTH levels following RYBP remained stable at 24 months, from 6.1 (IQR 4.7–8.7) to 6.4 (4.9–8.1) pmol/L. Furthermore, we failed to notice a significant improvement in PTH levels following RYBP among those with higher PTH levels preoperatively. CONCLUSION: Higher PTH levels following RYBP, compared to SG, may imply we are undertreating patients who are inherently subjected to a greater degree of malabsorption and underlying nutritional deficiencies. This finding calls for a tailored supplementation protocol, particularly for those with high preoperative PTH levels undergoing RYBP, to prevent deficiencies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-021-01348-3. BioMed Central 2021-09-25 /pmc/articles/PMC8464128/ /pubmed/34563195 http://dx.doi.org/10.1186/s12893-021-01348-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Suthakaran, Reshi
Indigahawela, Imeshi
Mori, Krinal
Lim, Kiat
Aly, Ahmad
Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery
title Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery
title_full Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery
title_fullStr Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery
title_full_unstemmed Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery
title_short Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery
title_sort preventing calcium and vitamin d deficiencies following weight loss and metabolic surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464128/
https://www.ncbi.nlm.nih.gov/pubmed/34563195
http://dx.doi.org/10.1186/s12893-021-01348-3
work_keys_str_mv AT suthakaranreshi preventingcalciumandvitaminddeficienciesfollowingweightlossandmetabolicsurgery
AT indigahawelaimeshi preventingcalciumandvitaminddeficienciesfollowingweightlossandmetabolicsurgery
AT morikrinal preventingcalciumandvitaminddeficienciesfollowingweightlossandmetabolicsurgery
AT limkiat preventingcalciumandvitaminddeficienciesfollowingweightlossandmetabolicsurgery
AT alyahmad preventingcalciumandvitaminddeficienciesfollowingweightlossandmetabolicsurgery